Delivery Order SPE2DB22D3501-SPE2DB25FWW59
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,449.57 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $39,774.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials with a contract value of $27,818.98. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement. The award was competitively awarded with no set-aside designation and will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Bridion 200 mg/2 ml vials with a ceiling value of $13,804.03. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. Performance of the order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $12,673.71 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 ml vials on August 21, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.29 to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials (5 mL quantity) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $60,425.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a $1,095.66 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, which is expected to be completed by September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $22,659.00 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWW59Delivery Order
The Defense Logistics Agency awarded a $3,206.55 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract, which was competitively awarded without set-aside designation, calls for delivery completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill complex pharmaceutical requirements across multiple therapeutic domains, ranging from specialty medications and vaccines to medical devices and supplies. This delivery order for Bridion, a neuromuscular blocking agent reversal medication, represents a routine fulfillment of the company's prime vendor role in supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/14/25 |